BIO-key Posts 15-Cent Per Share Loss in Q1 Following Nasdaq Delisting
BKYI sits 27% above its 52-week low of $3.1 on light trading volume (0.2× avg).
Summary
BIO-key International reported a first-quarter loss of 15 cents per share. This financial result comes shortly after the company's common stock was suspended from Nasdaq and moved to OTC Markets due to non-compliance, as disclosed in an 8-K filing on May 12. The reported loss further highlights the company's ongoing financial challenges and operational instability, which are critical considerations for investors given its recent delisting. Traders will be monitoring future financial disclosures for signs of improvement or further deterioration.
At the time of this announcement, BKYI was trading at $3.94 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.6M. The 52-week trading range was $3.10 to $19.70. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.